M Steiert,F J Schmitz
M Steiert
PD-140248 is an isomerase inhibitor and topoisomerase II inhibitor under development by Parke-Davis and Co as a potential treatment for bacterial infection. Although no details of active development have been published in the scientific lit...
L Pradella
L Pradella
ONO-5046 (sivelestat) is a competitive inhibitor of human neutrophil elastase from Ono Pharmaceutical, which is awaiting FDA approval for the treatment of pulmonary fibrosis and idiopathic interstitial pneumonia [349488]. An NDA was filed i...
A R Moore
A R Moore
A review of patent literature surrounding the use of hyaluronan (HA) and its derivatives, or agents capable of modulating endogenous levels, is presented. Indications are many and varied and include arthritis, abnormal wound healing, neopla...
V Subbiah,L Katwa
V Subbiah
IUPHAR Southeast Asian-Western Pacific Region--eighth Meeting. Pharmacology in the Next Millennium. 1-5 November 1999, Taipei, Taiwan [0.03%]
国际药理学联合会东南亚-西太平洋地区第八届会议。面向新千年地药物动力学研究进展。1999年11月1～5日，台北
B Tomlinson
B Tomlinson
This conference focused on some areas of particular interest to pharmacologists in the Asia-Pacific region, including prostanoids, drug metabolism and drugs from traditional Chinese herbs. Areas covered in the prostanoid sessions included r...
Predictive toxicology in drug discovery--second international conference. New technologies for predicting toxic responses at an early stage. 10-11 November 1999, New Orleans, LA, USA [0.03%]
药物研究中的预测毒理学第二次国际会议──早期预测毒性反应的新技术美国路易斯安那州新奥尔良市 1999年11月10～11日
J Tugwood
J Tugwood
This meeting focused on the problems facing the pharmaceutical industry, given the need for faster and higher throughput toxicity testing, and how emerging technologies are being applied to address this need. Inevitably, the emphasis was on...
C Korstanje
C Korstanje
This symposium, jointly organized by the British Pharmacological Society, the Pharmaceutical Sciences Group of the Royal Pharmaceutical Society and the National Society for Epilepsy, provided comprehensive information on anti-epileptic ther...